IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#4766
Positioning
Market Dominance
Services
Computer Software
$17M
Khurram P. Sheikh
KINS Technology Group Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = CXAI ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$YALA Yalla Group Ltd | 75 | 89 | 99 | 80 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$GRVY GRAVITY Co., Ltd. | 75 | 82 | 96 | 71 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ISSC INNOVATIVE SOLUTIONS & SUPPORT INC | 73 | 81 | 88 | 94 | 25.0x | 14.1x | 17.1% | 10.3% | 35.5% | 14.6% | 10.1% | 105.2% | 0.0% | 41.0x | $244M | VS | |
$AER AerCap Holdings N.V. | 72 | 60 | 87 | 84 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$HCSG HEALTHCARE SERVICES GROUP INC | 72 | 74 | 88 | 88 | 7.1x | 6.1x | 28.9% | 20.8% | 20.8% | 9.9% | 9.3% | 8.5% | 0.0% | 1.0x | $1.2B | VS | |
$LQDT LIQUIDITY SERVICES INC | 72 | 90 | 88 | 68 | 24.9x | 14.3x | 14.1% | 8.3% | 45.7% | 8.5% | 6.2% | 28.1% | 0.0% | 0.0x | $736M | VS | |
$TRTNpA Triton International Ltd | 71 | 70 | 89 | 70 | - | 1.7x | 0.0% | - | 97.4% | 58.0% | 37.4% | - | 8.8% | 264.0x | $2.5B | VS | |
$EDU New Oriental Education & Technology Group Inc. | 71 | 83 | 52 | 77 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$NTES NetEase, Inc. | 71 | 88 | 93 | 68 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$UTI UNIVERSAL TECHNICAL INSTITUTE INC | 70 | 86 | 86 | 72 | 43.2x | 16.0x | 15.3% | 5.8% | 100.0% | 6.9% | 5.2% | 15.1% | 0.0% | 24.0x | $1.8B | VS | |
$CXAI CXApp Inc. | 25 | 19 | 10 | 4 | - | - | -87.6% | -46.8% | 85.8% | -294.9% | -239.6% | 55.8% | 0.0% | 87.0x | $17M | ||
| SECTOR BENCH | - | - | - | - | - | 23.7x | 11.7x | 5.7% | 2.4% | 64.6% | 4.5% | 2.8% | 8.6% | 0.0% | 0.3x | - | REF |
CXApp Inc. (CXAI) receives a "Avoid" rating with a composite score of 25.1/100. It ranks #4766 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
Lagging peers — losers tend to keep underperforming
Expensive relative to fundamentals — limited margin of safety
Weak fundamentals — higher risk of value trap
Average volatility — neutral timing signal
Moderate investment profile
Below-average composite — caution warranted
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Services sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for CXAI.
View All Ratings| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 19 | 4 | +15ALPHA |
| MOMENTUM | 4 | 2 | +2NEUTRAL |
| VALUATION | 10 | 5 | +5NEUTRAL |
| INVESTMENT | 46 | 81 | -35DRAG |
| STABILITY | 38 | 33 | +5NEUTRAL |
| SHORT INT | 52 | 59 | -7DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC -208.4% vs WACC 6.9% (spread -215.3%)
GM 86% vs sector 65%, OM -295% vs sector 5%
Capital turnover 0.77x, R&D intensity 144.5%
Rev growth 56%, 3yr history
Interest coverage N/A
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
We rate CXApp Inc. (CXAI) as Avoid with a composite score of 25.1/100 at a current price of $0.18. The stock falls in the bottom quintile, and the multi-factor weakness suggests a high probability of continued underperformance.
CXApp Inc. holds a top-quartile position (#0 of 50) within the Services sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 25.1/100 places it at rank #4766 in our full universe.
No Moat
High
Poor
Fair Value
Gross margins of 86% signal strong pricing power.
Stable competitive position in a defensive sector.
Weak momentum suggests persistent institutional selling pressure.
Below-average quality raises earnings sustainability concerns.
Vulnerability to macroeconomic shocks and interest rate volatility.
CXApp Inc. represents a avoid based on multi-factor quantitative performance.
Our quantitative model flags CXApp Inc. with an Avoid rating, assigning a composite score of 25.1/100 and 1 out of 5 stars. Ranked #4766 of 7,333 stocks, CXAI falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.
CXApp Inc. registers a weak quality score of just 19/100, indicating significant profitability challenges. The company reports a return on equity of -87.6% (sector avg: 5.7%), gross margins of 85.8% (sector avg: 64.6%), net margins of -239.6% (sector avg: 2.8%). Low quality scores are often associated with businesses in turnaround mode, early-stage growth, or structurally challenged industries.
CXAI registers a value score of just 10/100, suggesting the stock trades at a significant premium to its fundamental metrics. Key valuation metrics include a P/B ratio of 0.46x. High-premium valuations like this require strong future execution to avoid multiple compression, and downside risk is elevated if growth disappoints.
With an investment score of 46/100, CXAI exhibits moderate growth-oriented spending. Key growth metrics include revenue growth of 55.8% vs. a sector average of 8.6% and a return on assets of -46.8% (sector: 2.4%). The company appears to be balancing growth investments with capital returns, though the pace of investment may not be enough to accelerate top-line growth meaningfully.
CXApp Inc. is experiencing notably weak momentum with a score of just 4/100. The stock has underperformed its peers and is trending below major moving averages. Revenue growth stands at 55.8% year-over-year, while a beta of -0.08 reflects its sensitivity to broader market moves. While deep momentum weakness can occasionally present value opportunities, it often reflects deteriorating fundamentals or structural headwinds that may persist.
CXAI's stability score of 38/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of -0.08 and a debt-to-equity ratio of 87.00x (sector avg: 0.3x). Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.
The short interest score of 52/100 for CXAI suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include elevated leverage (D/E: 87.00x), micro-cap liquidity risk. With a $17M market cap (micro-cap), CXApp Inc. may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
CXApp Inc. is a micro-cap company in the Services sector, ranked #0 of 50 in its sector (100th percentile) and #4766 of 7,333 overall (35th percentile). Key comparisons include ROE of -87.6% trailing the 5.7% sector median and operating margins of -294.9% below the 4.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Services peers.
While CXAI currently exhibits a AVOID profile, superior opportunities exist within the SERVICES sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Services Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Momentum (4) would have the largest impact on the composite score.
ROE 1626% BELOW SECTOR MEDIAN
Gross Margin 33% ABOVE SECTOR MEDIAN (FAVORABLE)
Op. Margin 6654% BELOW SECTOR MEDIAN
Above 50MA
37.18%
Net New Highs
+51081
Multi-Campus Rollout Illustrates How Data-Driven Workplace Systems Align Engagement, Utilization, and Hybrid Operations PALO ALTO, CA / ACCESS Newswire / December 30, 2025 /CXApp Inc. (Nasdaq:CXAI), the emerging category leader in AI-powered workplace ...
Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings. Travelers reported a mixed first quarter, with earnings lagging analyst' expectations. Core income per share reached $4.69 from $4.11 a year ago, missing the $4.90 consensus forecast. Net income per share rose to $4.80 from $4.13 a year earlier. Travelers shares dipped 8.1% to $205.03 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers INVO Bioscience, Inc. (NASDAQ: INVO) shares shot up 256% to $2.78 after the company reported a year-over-year increase in fourth-quarter revenue results and said it remains on track to reach its goal of reaching break-even or profitability within its current operations in 2024. Edible Garden AG Incorporated (NASDAQ: EDBL) gained 112% to $9.73 after the company reported preliminary first quarter FY24 results. Sintx Technologies, Inc. (NASDAQ: SINT) jumped 53% to $0.0350. VIA optronics AG (NYSE: VIAO) shares gained 50.4% to $0.3924 after dipping over 15% on Tuesday. AERWINS Technologies Inc. (NASDAQ: AWIN) jumped 42.2% to $4.70. The Children's Place, Inc. (NASDAQ: PLCE) climbed 35.5% to $9.64 after the company announced it entered into a new financing agreement with Mithaq Capital. Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) gained 32% to $5.38 after the company announced that it submitted three proposals since February to acquire all of the outstanding shares of common stock of Vanda Pharmaceuticals and confirmed that its most recent proposal to acquire Vanda remains open for Vanda and its Board of Directors to consider. EZGO Technologies Ltd. (NASDAQ: EZGO) gained 28% to $2.20. EZGO entered into a strategic cooperation framework agreement with Woteam to jointly explore the Southeast Asian Market. CXApp Inc. (NASDAQ: CXAI) shares rose 25% to $4.89 after the company announced 24% ARR growth in 2023. TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) rose 19.6% to $2.0461. WiSA Technologies, Inc. (NASDAQ:
Shares of INVO Bioscience, Inc. (NASDAQ: INVO) rose sharply in today’s pre-market trading after reporting fourth-quarter results. The company said quarterly revenue surged 397% year-over-year to $1,381,754, from $278,142 in the year-ago period, according to data from Benzinga Pro. INVO Bioscience shares jumped 73.1% to $1.35 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Mobile Global Esports Inc. (NASDAQ: MGAM) shares gained 36.1% to $0.1565 in pre-market trading after falling around 9% on Tuesday. On April 16, Maxim Group analyst Jack Vander Aarde downgraded Mobile Global Esports from Buy to Hold. Chromocell Therapeutics Corporation (NYSE: CHRO) gained 29.1% to $2.35 in pre-market trading after falling around 7% on Tuesday. Clene Inc. (NASDAQ: CLNN) gained 27.9% to $0.3965 in pre-market trading after the company announced Phase 2 VISIONARY-MS long term extension study results at the 2024 American Academy of Neurology Annual Meeting. VIA optronics AG (NYSE: VIAO) shares ...
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly issued a weak outlook. Ulta Beauty shares dipped 13.7% to $448.08 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers ARCA biopharma, Inc. (NASDAQ: ABIO) climbed 108% to $3.5549 after the company and Oruka Therapeutics announced a merger agreement. Kintara Therapeutics, Inc. (NASDAQ: KTRA) shares gained 89% to $0.1906 after the company entered a merger agreement with TuHURA Biosciences. Next Technology Holding Inc. (NASDAQ: NXTT) rose 57.4% to $6.42. Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) shares climbed 39.3% to $5.45. Vanda Pharmaceuticals' Fanapt® received U.S. FDA approval for the acute treatment of Bipolar I Disorder. VivoPower International PLC (NASDAQ: VVPR) shares gained 39% to $8.20 after the company declared a capital management strategy including a stock buyback program of up to $5 million. Next.e.GO N.V. (NASDAQ: EGOX) gained 32.7% to $0.0345. XTI Aerospace, Inc. (NASDAQ: XTIA) rose 32.2% to $4.63. BestGrowthStocks.com issued comprehensive evaluation of XTI Aerospace, Inc. Brooge Energy Limited (NASDAQ: BROG) gained 28.8% to $3.0790. Addex Therapeutics Ltd (NASDAQ: ADXN) rose 24.6% to $16.21 after the company and funds affiliated with Perceptive Advisors announced the launch of Neurosterix. Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH) gained 24.3% to $0.3981 after gaining 13% on Tuesday. LAMF Global Ventures Corp. I (NASDAQ: LGVC) gained 22.7% to $13.21. ViewLAMF Global Ventures Corp. I shareholders approved previously announced business combination with Nuvo Group Ltd. Quhuo Limited (NASDAQ: QH) rose 21.7% to $0.6501 after reporting unaudited financial results for the second half and full year 2023. Destiny Tech100 Inc. (NYSE: DXYZ) gained 21.4% to $25.77. OneMedNet Corporation (NASDAQ: ONMD) gained 21.2% to $0.9600. OneMedNet announced it entered a securities purchase agreement dated Mar. 28 providing up to $4.54 million in funding through private placement ...
Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss. Stryve Foods posted adjusted loss of $1.90 per share, versus market estimates for a loss of $1.96 per share. The company’s sales came in at $2.887 million versus expectations of $5.009 million, according to data from Benzinga Pro. Stryve Foods shares dipped 25.2% to $1.0965 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers VivoPower International PLC (NASDAQ: VVPR) shares surged 315% to $6.10 after the company's Tembo subsidiary announced it will merge with the Nasdaq-listed Cactus Acquisition Corp. 1 Limited. Trio Petroleum Corp. (NYSE: TPET) gained 73.8% to $0.1797 after jumping over 21% on Monday. XTI Aerospace, Inc. (NASDAQ: XTIA) rose 63.9% to $3.3750 after jumping 19% on Monday. Kidpik Corp. (NASDAQ: PIK) shares climbed 35.2% to $5.90 after the company entered a merger agreement with Nina Footwear. VirTra, Inc. (NASDAQ: VTSI) rose 32.8% to $12.67 after the company reported better-than-expected fourth-quarter results. MSP Recovery, Inc. (NASDAQ: LIFW) gained 26.9% to $0.8449 after a 13G filing showed Palantir Technologies reported a 6.5% stake in the company as of March 22, 2024. Aditxt, Inc. (NASDAQ: ADTX) gained 20% to $3.8204 after the company announced it will acquire Appili Therapeutics. TMC the metals company Inc. (NASDAQ: TMC) climbed 18.1% to $1.70. C3is Inc. (NASDAQ: CISS) rose 18% to $0.0426. Nexalin Technology, Inc. (NASDAQ: NXL) gained 18% to $2.2400. Nexalin Technology announced the appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board. Concord Medical Services Holdings Limited (NYSE: CCM) rose 17.7% to $0.6119. Jiuzi Holdings, Inc. (NASDAQ: JZXN) gained 10.7% to $4.43. Yatsen Holding Limited (NYSE: YSG) rose 10% to $2.52. ChampionX Corporation (NASDAQ: CHX) gained 9.5% to $38.78 ...